Alimentary Pharmacology and Therapeutics
Издатель: Wiley · ISSN 02692813 · 87 статей
- Editorial: Microscopic Colitis—Are Medications Linked to Disease or Disease Investigation?
- Editorial: When It Comes to Gastrointestinal Bleeding, It's Not the Anticoagulant Therapy Itself That's the Problem, but How It's Being Managed
- Letter on: ‘Impact of Prior Biologic Mechanism of Action on Anti‐TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study’. Authors' Reply
- Letter on: ‘Impact of Prior Biologic Mechanism of Action on Anti‐TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study’
- Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD—Is This the Time for Model Informed Precision Dosing?
-
Development of a Clinical and Biomarker‐Based Score to Predict Microscopic Colitis in Patients With Chronic Watery Diarrhoea
ABSTRACT Background Colonoscopy with stepwise colonic biopsies is the only method for confirming microscopic colitis in patients with chronic watery diarrhoea. Several clinical scores (Cotter, Kane and Atieh) have been proposed to guide...
- Letter: LGP2 Q425R In Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Authors' Reply
-
Clinical Trial: Capsule Sponge as a Non‐Endoscopic Monitoring Tool in Eosinophilic Oesophagitis—A Prospective Real–World Multicentre Study
ABSTRACT Background and Aims Eosinophilic oesophagitis (EoE) is a chronic inflammatory condition requiring repeat endoscopy and biopsy for histological monitoring, which is invasive, resource‐intensive and burdensome for patients. The...
- Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply
- Letter: The Q425R Variant in Chronic Hepatitis Delta—Distinguishing Cirrhosis Prevalence From Portal Hypertension Severity. Authors' Reply
- Letter: Temporal Misalignment and Selective Adjustment in PPI Risk Estimates After FMT
-
Maternal Obesity Is Associated With Adverse Pregnancy Outcomes in Inflammatory Bowel Disease: A Matched Electronic Health Record Cohort Study
ABSTRACT Background We sought to define the prevalence of obesity in the first trimester of pregnancy among women with inflammatory bowel disease (IBD) and evaluate its association with adverse pregnancy outcomes. Methods...
-
Meta‐Analysis: Potassium‐Competitive Acid Blockers Versus Proton Pump Inhibitors for Gastroprotection in Patients Receiving Antiplatelet Therapy
ABSTRACT Background PPIs are standard for gastroprotection during antiplatelet therapy. However, certain PPIs, chiefly omeprazole and esomeprazole, inhibit cytochrome P450 2C19 (CYP2C19), which activates clopidogrel, whereas...
-
Management and Outcomes of Bleeding Ectopic Varices in Patients With Liver Cirrhosis: A Systematic Review and Pooled Analysis
ABSTRACT Background Bleeding ectopic varices is a rare but life‐threatening complication in patients with clinically significant portal hypertension and liver cirrhosis, with limited evidence available to guide treatment decisions. Aim...
-
Colonic Mast Cell Density and Diarrhoea: Evidence Against a Threshold Effect in Biopsies From 3508 Patients
ABSTRACT Background Elevated mast cell (MC) counts in colonic biopsies are frequently observed in patients with chronic diarrhoea or unspecific abdominal symptoms, potentially leading to a diagnosis of mast cell activation syndrome....
- Editorial: Seeing Through the Wall—Can Intestinal Ultrasound Guide Upadacitinib Dosing in Crohn's Disease?
-
Baseline Clearance and Early Troughs Identify Candidates for Early Therapeutic Drug Monitoring During Infliximab Induction in Inflammatory Bowel Disease
ABSTRACT Background and Aims The value of therapeutic drug monitoring during infliximab induction remains uncertain. We evaluated whether baseline infliximab clearance and early exposure metrics identify candidates for potential early...
- Letter: Diagnostic Assessment and Temporal Trends in Non‐Helicobacter pylori, Non‐NSAID Bleeding Ulcers. Authors' Reply
-
Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC, Warfarin and Non‐Anticoagulated Patients
ABSTRACT Background and Aims Reported outcomes after gastrointestinal bleeding (GIB) in anticoagulated patients are inconsistent, and comparisons with non‐anticoagulated patients are limited. We assessed whether anticoagulation status...
- Letter: Colorectal Cancer Risk After Faecal Immunochemical Testing—Which Risk Should Guide Referral?
- Long‐Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD‐ALD Prediction Index
- HLA‐A*11:01 Identifies Patients at Risk for Persistent Viraemia and Advanced Fibrosis in HDV Infection
- Treatment Patterns in Patients With Eosinophilic Oesophagitis Referred for Expert Consultation
- Clinical trial: The Effect on Intragastric pH and Pharmacokinetics of the PCAB Linaprazan Glurate in Healthy Subjects After Repeat‐Dose Administration for up to 14 Days
- Intestinal Ultrasound Predicts Primary Non‐Response and Maintenance Relapse in Upadacitinib‐Treated Active Crohn's Disease: A Multicenter, Prospective Cohort Study
- Association Between Proton Pump Inhibitor Use and Gastric Neuroendocrine Neoplasms in Autoimmune Gastritis: A Real‐World Propensity Score‐Matched Study From the Autoimmune gastRitis Italian netwOrk Study grOup
- Letter: Calendar Era or Antiviral Choice—What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection?
- Letter: The Microbiome‐Mediated Impact of Proton Pump Inhibitors on Spontaneous Bacterial Peritonitis
- Letter: Calendar Era or Antiviral Choice–What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection? Authors' Reply
- Letter: The Microbiome‐Mediated Impact of Proton Pump Inhibitors on Spontaneous Bacterial Peritonitis—Authors' Reply